tirzepatide drug mounjaro Users of Zepbound or Had Lower Blood Pressure in Study Eli Lilly weight-loss drug appears

They are FDA-approved and have been studied extensively, but they arent right for everyone

A literature search was conducted from January 2000 to December 2022 using multiple databases including Web of Science, Wiley, Springer, PubMed, Elsevier Science Direct, Google Scholar, the Core Collection, Scopus, and the Cochrane Library to collect and evaluate peer-reviewed literature regarding the neuroprotective role of metformin against DM-induced neurodegenerative events

Further, many employers (as high as 59% of employers with at least 5,000 workers) that offered such coverage said that use of GLP-1 medications was higher than expected, and 66% of the largest employers said that covering such drugs for weight loss had a significant impact on their health plans prescription drug spending

Acute Kidney Injury Some studies sponsored by Novo Nordisk suggest that semaglutide may actually help reduce the risk of kidney disease over the long term